On the public citation graph

Comparison of 68 Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology

0 signed · 184 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/(sici)1097-0045(20000501)43:2<150::aid-pros10>3.0.co;2-bopenalex-snapshot

A dual-monoclonal sandwich assay for prostate-specific membrane antigen: Levels in tissues, seminal fluid and urine

inferredcites →https://doi.org/10.1002/(sici)1522-2594(199912)42:6<1072::aid-mrm11>3.0.co;2-mopenalex-snapshot

On standardizing the MR image intensity scale

inferredcites →https://doi.org/10.1002/1097-0142(19900915)66:6<1225::aid-cncr2820660624>3.0.co;2-xopenalex-snapshot

Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate

inferredcites →https://doi.org/10.1007/s00259-014-2861-0openalex-snapshot

11C-Choline PET/pathology image coregistration in primary localized prostate cancer

inferredcites →https://doi.org/10.1007/s00259-015-3257-5openalex-snapshot

MRI versus 68Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer

inferredcites →https://doi.org/10.1016/j.acra.2008.01.022openalex-snapshot

Registration Methodology for Histological Sections and In Vivo Imaging of Human Prostate

inferredcites →https://doi.org/10.1016/j.eururo.2006.03.007openalex-snapshot

MRI-Guided Biopsy of the Prostate Increases Diagnostic Performance in Men with Elevated or Increasing PSA Levels after Previous Negative TRUS Biopsies

inferredcites →https://doi.org/10.1016/j.eururo.2013.05.048openalex-snapshot

The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review

inferredcites →https://doi.org/10.1016/j.eururo.2013.09.046openalex-snapshot

EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013

inferredcites →https://doi.org/10.1016/j.eururo.2014.10.033openalex-snapshot

Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis

inferredcites →https://doi.org/10.1016/j.eururo.2015.08.052openalex-snapshot

PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2

inferredcites →https://doi.org/10.1016/j.eururo.2015.12.053openalex-snapshot

Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer

inferredcites →https://doi.org/10.1016/j.ijrobp.2007.03.065openalex-snapshot

Clinically Significant Prostate Cancer Local Recurrence After Radiation Therapy Occurs at the Site of Primary Tumor: Magnetic Resonance Imaging and Step-Section Pathology Evidence

inferredcites →https://doi.org/10.1016/j.ijrobp.2015.02.004openalex-snapshot

Comparison of [11C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic Lesions

inferredcites →https://doi.org/10.1016/j.juro.2016.02.3000openalex-snapshot

Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer

inferredcites →https://doi.org/10.1016/j.radonc.2013.04.027openalex-snapshot

Boosting imaging defined dominant prostatic tumors: A systematic review

inferredcites →https://doi.org/10.1016/j.zemedi.2016.02.002openalex-snapshot

Personalized precision radiotherapy by integration of multi-parametric functional and biological imaging in prostate cancer: A feasibility study

inferredcites →https://doi.org/10.1016/s0022-5347(17)42876-xopenalex-snapshot

Morphometric and Clinical Studies on 68 Consecutive Radical Prostatectomies

inferredcites →https://doi.org/10.1016/s0090-4295(96)00184-7openalex-snapshot

Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

inferredcites →https://doi.org/10.1038/nrurol.2016.26openalex-snapshot

Current use of PSMA–PET in prostate cancer management

inferredcites →https://doi.org/10.1111/j.1365-2559.2007.02635.xopenalex-snapshot

Prostate‐specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique

inferredcites →https://doi.org/10.1111/j.1464-410x.2010.09436.xopenalex-snapshot

The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer

inferredcites →https://doi.org/10.1158/0008-5472.can-05-2018openalex-snapshot

Prospective Identification of Tumorigenic Prostate Cancer Stem Cells

inferredcites →https://doi.org/10.1158/1078-0432.ccr-11-2711openalex-snapshot

Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer

inferredcites →https://doi.org/10.1172/jci70354openalex-snapshot

Tracking the clonal origin of lethal prostate cancer

inferredcites →https://doi.org/10.2214/ajr.09.2651openalex-snapshot

Diffusion-Weighted MRI of Peripheral Zone Prostate Cancer: Comparison of Tumor Apparent Diffusion Coefficient With Gleason Score and Percentage of Tumor on Core Biopsy

inferredcites →https://doi.org/10.2967/jnumed.115.154336openalex-snapshot

18F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer

inferredcites →https://doi.org/10.2967/jnumed.115.169243openalex-snapshot

Correlation of Intraprostatic Tumor Extent with 68Ga-PSMA Distribution in Patients with Prostate Cancer

inferredcites →https://doi.org/10.3390/ph7070779openalex-snapshot

Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer

inferredcites →https://doi.org/10.7150/thno.15344openalex-snapshot

68Ga-HBED-CC-PSMA PET/CT Versus Histopathology In Primary Localized Prostate Cancer: A Voxel-Wise Comparison

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4772543openalex-extracted

Machine Learning Based on Adaptive Mutation Squirrel Search Algorithm for Lung Cancer Imaging-Gene Multimodal Data Correlation a Nalysis and Subtype Diagnosis

inferred← citeshttps://doi.org/10.1002/cnr2.1450openalex-snapshot

High‐dose‐rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome

inferred← citeshttps://doi.org/10.1002/pros.23812openalex-snapshot

Comparison of preoperative locoregional Ga‐68 PSMA‐11 PET‐CT and mp‐MRI results with postoperative histopathology of prostate cancer

inferred← citeshttps://doi.org/10.1002/pros.24694openalex-snapshot

Key learnings from concordant systematic biopsies in prostate‐specific membrane antigen positron emission tomography/computed tomography‐guided prostate biopsies: Enhancing targeting accuracy

inferred← citeshttps://doi.org/10.1007/978-3-030-38261-2_15openalex-snapshot

T Staging and Target Volume Definition by Imaging in GU Tumors

inferred← citeshttps://doi.org/10.1007/978-3-030-42618-7_27openalex-snapshot

Molecular Imaging in Photon Radiotherapy

inferred← citeshttps://doi.org/10.1007/978-3-031-45489-9_14openalex-snapshot

Prostate Cancer

inferred← citeshttps://doi.org/10.1007/978-3-031-66754-1_21openalex-snapshot

Diagnostic Performance of PET-Based Targeted Fusion Biopsy in Prostate Cancer

inferred← citeshttps://doi.org/10.1007/978-3-032-21415-7_14openalex-snapshot

Molecular Imaging in Photon Radiotherapy

inferred← citeshttps://doi.org/10.1007/978-3-319-42603-7_69-1openalex-snapshot

Local and Systemic Staging by Modern Imaging Modalities in Prostate Cancer

inferred← citeshttps://doi.org/10.1007/978-3-319-42623-5_69openalex-snapshot

Local and Systemic Staging by Modern Imaging Modalities in Prostate Cancer

inferred← citeshttps://doi.org/10.1007/978-981-97-8389-2_27openalex-snapshot

Nuclear Medicine in Oncology

inferred← citeshttps://doi.org/10.1007/s00066-018-1417-9openalex-snapshot

Comparison of 68 Ga-PSMA ligand PET/CT versus conventional cross-sectional imaging for target volume delineation for metastasis-directed radiotherapy for metachronous lymph node metastases from prostate cancer

inferred← citeshttps://doi.org/10.1007/s00120-021-01598-2openalex-snapshot

Interdisziplinärer Expertenkonsensus zu Innovationen der bildgebenden Diagnostik und radionuklidbasierten Therapien des fortgeschrittenen Prostatakarzinoms

inferred← citeshttps://doi.org/10.1007/s00259-017-3882-2openalex-snapshot

Current status of theranostics in prostate cancer

inferred← citeshttps://doi.org/10.1007/s00259-018-3979-2openalex-snapshot

The central zone has increased 68Ga-PSMA-11 uptake: “Mickey Mouse ears” can be hot on 68Ga-PSMA-11 PET

inferred← citeshttps://doi.org/10.1007/s00259-018-4037-9openalex-snapshot

68Ga-PSMA-617 PET/CT: a promising new technique for predicting risk stratification and metastatic risk of prostate cancer patients

inferred← citeshttps://doi.org/10.1007/s00259-020-04827-6openalex-snapshot

Intraindividual comparison between 68Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients

inferred← citeshttps://doi.org/10.1007/s00259-020-05111-3openalex-snapshot

Uncovering the invisible—prevalence, characteristics, and radiomics feature–based detection of visually undetectable intraprostatic tumor lesions in 68GaPSMA-11 PET images of patients with primary prostate cancer

inferred← citeshttps://doi.org/10.1007/s00345-019-02677-yopenalex-snapshot

The role of MRI for detection and staging of radio- and focal therapy-recurrent prostate cancer

inferred← citeshttps://doi.org/10.1007/s00345-019-03066-1openalex-snapshot

Simultaneous whole-body PET/MRI with integrated multiparametric MRI for primary staging of high-risk prostate cancer

inferred← citeshttps://doi.org/10.1007/s00345-020-03344-3openalex-snapshot

Novel PET imaging methods for prostate cancer

inferred← citeshttps://doi.org/10.1007/s00345-022-04172-3openalex-snapshot

Axumin (18F-Fluciclovine) PET imaging in men exhibiting no clinically significant cancer on initial negative biopsy of PI-RADS 4 and 5 regions of interest

inferred← citeshttps://doi.org/10.1007/s11547-018-0929-9openalex-snapshot

68Ga-PSMA-PET: added value and future applications in comparison to the current use of choline-PET and mpMRI in the workup of prostate cancer

inferred← citeshttps://doi.org/10.1007/s11654-025-00689-2openalex-snapshot

Einsatz von funktioneller Bildgebung zur Therapieplanung

inferred← citeshttps://doi.org/10.1007/s11934-017-0736-1openalex-snapshot

Performance of 68Ga-PSMA PET/CT for Prostate Cancer Management at Initial Staging and Time of Biochemical Recurrence

inferred← citeshttps://doi.org/10.1007/s12149-025-02033-8openalex-snapshot

Superiority of 68Ga-PSMA-11 PET/CT over mpMRI for lateralization accuracy of diagnosing intra-glandular prostate cancer lesions: avoiding fluke targeting

inferred← citeshttps://doi.org/10.1007/s12312-021-01009-9openalex-snapshot

Fokale Strahlendosiseskalation bei Patienten mit primärem Prostatakarzinom (HypoFocal) – eine prospektive, multizentrische, nichtrandomisierte, 2‑armige Studie

inferred← citeshttps://doi.org/10.1007/s40336-017-0228-9openalex-snapshot

Multimodal imaging in focal therapy planning and assessment in primary prostate cancer

inferred← citeshttps://doi.org/10.1007/s40336-023-00582-4openalex-snapshot

PSMA PET/CT and PET/MRI in primary staging of prostate cancer and its effect on patient management

inferred← citeshttps://doi.org/10.1016/j.adro.2019.09.004openalex-snapshot

Dosimetric Evaluation of PSMA PET-Delineated Dominant Intraprostatic Lesion Simultaneous Infield Boosts

inferred← citeshttps://doi.org/10.1016/j.brachy.2023.09.001openalex-snapshot

Viability of focal dose escalation to prostate cancer intraprostatic lesions using HDR prostate brachytherapy

inferred← citeshttps://doi.org/10.1016/j.canlet.2022.215883openalex-snapshot

Prostate specific membrane antigen positron emission tomography in primary prostate cancer diagnosis: First-line imaging is afoot

inferred← citeshttps://doi.org/10.1016/j.ctro.2020.10.004openalex-snapshot

Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial

inferred← citeshttps://doi.org/10.1016/j.ctro.2022.05.005openalex-snapshot

Feasibility of biology-guided radiotherapy using PSMA-PET to boost to dominant intraprostatic tumour

inferred← citeshttps://doi.org/10.1016/j.ejrad.2019.02.028openalex-snapshot

Comparison of PET/MRI with multiparametric MRI in diagnosis of primary prostate cancer: A meta-analysis

inferred← citeshttps://doi.org/10.1016/j.ejrad.2023.111274openalex-snapshot

68Ga-prostate specific membrane antigen-11 PET/CT versus multiparametric MRI in the detection of primary prostate cancer: A systematic review and head-to-head comparative meta-analysis

inferred← citeshttps://doi.org/10.1016/j.euf.2025.10.014openalex-snapshot

Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer—Oncological Outcome from Long-term Follow-up

inferred← citeshttps://doi.org/10.1016/j.euo.2022.04.006openalex-snapshot

Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography–targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis

inferred← citeshttps://doi.org/10.1016/j.euros.2023.01.010openalex-snapshot

A Systematic Review of the Variability in Performing and Reporting Intraprostatic Prostate-specific Membrane Antigen Positron Emission Tomography in Primary Staging Studies

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2020.07.014openalex-snapshot

Interim Results of a Prospective Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Reirradiation Trial for Locally Recurrent Prostate Cancer

inferred← citeshttps://doi.org/10.1016/j.ijrobp.2025.03.033openalex-snapshot

PSMA-PET-Guided Intraprostatic Boost in Prostate SBRT (PROBE): A Phase 2 Trial

inferred← citeshttps://doi.org/10.1016/j.jconrel.2026.114939openalex-snapshot

Lipidized deferoxamine nanomedicines (DFOsomes) against iron overload

inferred← citeshttps://doi.org/10.1016/j.juro.2018.01.079openalex-snapshot

68 Ga-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study

inferred← citeshttps://doi.org/10.1016/j.phro.2018.10.001openalex-snapshot

Multimodal imaging for radiation therapy planning in patients with primary prostate cancer

inferred← citeshttps://doi.org/10.1016/j.phro.2024.100645openalex-snapshot

A review of whole gland prostate brachytherapy with focal dose escalation to intra-prostatic lesions: Clinical efficacy and technical aspects

inferred← citeshttps://doi.org/10.1016/j.prro.2020.11.006openalex-snapshot

68Ga-PSMA-11 PET, 18F-PSMA-1007 PET, and MRI for Gross Tumor Volume Delineation in Primary Prostate Cancer: Intermodality and Intertracer Variability

inferred← citeshttps://doi.org/10.1016/j.prro.2024.06.006openalex-snapshot

Target Volume Optimization for Localized Prostate Cancer

inferred← citeshttps://doi.org/10.1016/j.prro.2024.09.017openalex-snapshot

F18-DCFPyL PSMA-PET/CT Versus MRI: Identifying the Prostate Cancer Region Most at Risk of Radiation Therapy Recurrence for Tumor Dose Escalation

inferred← citeshttps://doi.org/10.1016/j.radonc.2017.04.021openalex-snapshot

Evaluation of intensity modulated radiation therapy dose painting for localized prostate cancer using 68 Ga-HBED-CC PSMA-PET/CT: A planning study based on histopathology reference

inferred← citeshttps://doi.org/10.1016/j.radonc.2018.02.006openalex-snapshot

Influence of inhomogeneous radiosensitivity distributions and intrafractional organ movement on the tumour control probability of focused IMRT in prostate cancer

inferred← citeshttps://doi.org/10.1016/j.radonc.2019.06.023openalex-snapshot

Stereotactic body radiation therapy with optional focal lesion ablative microboost in prostate cancer: Topical review and multicenter consensus

inferred← citeshttps://doi.org/10.1016/j.radonc.2019.07.002openalex-snapshot

Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of reference

inferred← citeshttps://doi.org/10.1016/j.radonc.2019.07.005openalex-snapshot

[68Ga-]PSMA-11 PET/CT and multiparametric MRI for gross tumor volume delineation in a slice by slice analysis with whole mount histopathology as a reference standard – Implications for focal radiotherapy planning in primary prostate cancer

inferred← citeshttps://doi.org/10.1016/j.radonc.2023.110070openalex-snapshot

Using multiparametric Magnetic Resonance Imaging and Prostate Specific Membrane Antigen Positron Emission Tomography to detect and delineate the gross tumour volume of intraprostatic lesions – A systematic review and meta-analysis

inferred← citeshttps://doi.org/10.1016/j.remn.2024.01.001openalex-snapshot

Correlación entre los índices estandarizados SUVmáx de la PET/TC con [68Ga]Ga-PSMA-I&T pre-prostatectomía radical y los resultados histopatológicos finales: un análisis en profundidad

inferred← citeshttps://doi.org/10.1016/j.remnie.2024.02.002openalex-snapshot

Correlation between pre-radical prostatectomy standardized SUVmax ratios detected on 68Ga-PSMA-I&T PET/CT and final histopathology outcomes: an in-depth analysis

inferred← citeshttps://doi.org/10.1016/j.ymeth.2017.07.009openalex-snapshot

New aspects of molecular imaging in prostate cancer

inferred← citeshttps://doi.org/10.1038/s41391-020-00270-8openalex-snapshot

Diagnostic ability of Ga-68 PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4–5 index lesions undergoing radical prostatectomy

inferred← citeshttps://doi.org/10.1038/s41391-020-00292-2openalex-snapshot

Evaluating F-18-PSMA-1007-PET in primary prostate cancer and comparing it to multi-parametric MRI and histopathology

inferred← citeshttps://doi.org/10.1038/s41598-020-67385-9openalex-snapshot

Comparison of 68Ga-PSMA-617 PET/CT with mpMRI for the detection of PCa in patients with a PSA level of 4–20 ng/ml before the initial biopsy

inferred← citeshttps://doi.org/10.1038/s41598-021-85028-5openalex-snapshot

The impact of the co-registration technique and analysis methodology in comparison studies between advanced imaging modalities and whole-mount-histology reference in primary prostate cancer

inferred← citeshttps://doi.org/10.1038/s41598-023-32301-4openalex-snapshot

Weakly supervised label propagation algorithm classifies lung cancer imaging subtypes

inferred← citeshttps://doi.org/10.1053/j.semnuclmed.2017.05.007openalex-snapshot

Clinical Applications of Radiolabeled Peptides for PET

inferred← citeshttps://doi.org/10.1053/j.semnuclmed.2018.07.004openalex-snapshot

Nuclear Medicine Imaging of Prostate Cancer in the Elderly

inferred← citeshttps://doi.org/10.1053/j.semnuclmed.2019.02.001openalex-snapshot

New Targets for PET Molecular Imaging of Prostate Cancer

inferred← citeshttps://doi.org/10.1053/j.semnuclmed.2019.02.002openalex-snapshot

Molecular Imaging and Theranostics—A Multidisciplinary Approach

inferred← citeshttps://doi.org/10.1053/j.semnuclmed.2021.11.012openalex-snapshot

Clinical Use of PET/MR in Oncology: An Update

inferred← citeshttps://doi.org/10.1053/j.semnuclmed.2025.03.006openalex-snapshot

Impact of PSMA PET on Radiation Oncology Planning

inferred← citeshttps://doi.org/10.1055/a-0621-3205openalex-snapshot

Aktueller Stand der PSMA-PET-Diagnostik beim Prostatakarzinom

inferred← citeshttps://doi.org/10.1055/s-0044-1779749openalex-snapshot

Comparison of Ga-68 PSMA PET/CT and Multiparametric MRI for Initial Detection and Staging of Prostate Cancer

inferred← citeshttps://doi.org/10.1080/14796694.2026.2714703openalex-snapshot

PSMA-PET/mpMRI-guided focal dose-escalated stereotactic body radiotherapy for localized prostate cancer: study protocol for a prospective, randomized controlled trial

inferred← citeshttps://doi.org/10.1097/cco.0000000000000439openalex-snapshot

Advances in prostate-specific membrane antigen PET of prostate cancer

inferred← citeshttps://doi.org/10.1097/cm9.0000000000003204openalex-snapshot

Preliminary clinical practice of radical prostatectomy without preoperative biopsy

inferred← citeshttps://doi.org/10.1097/coc.0000000000001314openalex-snapshot

FDA-Approved Radiopharmaceuticals in Oncologic PET Imaging

inferred← citeshttps://doi.org/10.1097/mnm.0000000000001283openalex-snapshot

Pilot study comparing dominant intraprostatic lesion volume using Ga-68 prostate-specific membrane antigen PET-computed tomography and multiparametric MRI

inferred← citeshttps://doi.org/10.1097/mnm.0000000000001743openalex-snapshot

Histopathology-validated lesion detection rates of clinically significant prostate cancer with mpMRI, [68Ga]PSMA-11-PET and [11C]Acetate-PET

inferred← citeshttps://doi.org/10.1097/mnm.0000000000002048openalex-snapshot

An assessment of conformance to structured reporting framework in 68Ga prostate-specific membrane antigen PET/computed tomography for prostate cancer staging

inferred← citeshttps://doi.org/10.1097/rct.0000000000001116openalex-snapshot

Comparison of MRI, PSMA PET/CT, and Fusion PSMA PET/MRI for Detection of Clinically Significant Prostate Cancer

inferred← citeshttps://doi.org/10.1097/rlu.0000000000003440openalex-snapshot

Delayed 68Ga-PSMA PET/CT Image-Guided Biopsy for Low-Grade Adenocarcinoma in Benign Prostatic Hyperplasia

inferred← citeshttps://doi.org/10.1097/rlu.0000000000004646openalex-snapshot

Comparing the Detection Performance Between Multiparametric Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen PET/CT in Patients With Localized Prostate Cancer

inferred← citeshttps://doi.org/10.1111/1754-9485.13284openalex-snapshot

Assessing the accuracy of 68Ga‐PSMA PET/CT compared with MRI in the initial diagnosis of prostate malignancy: A cohort analysis of 114 consecutive patients

inferred← citeshttps://doi.org/10.1111/1754-9485.13369openalex-snapshot

Current state of prostate‐specific membrane antigen PET/CT imaging–targeted biopsy techniques for detection of clinically significant prostate cancer

inferred← citeshttps://doi.org/10.1111/1754-9485.13382openalex-snapshot

Combination of MRI prostate and 18F‐DCFPyl PSMA PET / CT detects all clinically significant prostate cancers in treatment‐naive patients: An international multicentre retrospective study

inferred← citeshttps://doi.org/10.1111/bju.14648openalex-snapshot

Voxel‐wise correlation of positron emission tomography/computed tomography with multiparametric magnetic resonance imaging and histology of the prostate using a sophisticated registration framework

inferred← citeshttps://doi.org/10.1111/bju.14794openalex-snapshot

Diagnostic accuracy of 68 Ga‐prostate‐specific membrane antigen ( PSMA ) positron‐emission tomography ( PET ) and multiparametric (mp) MRI to detect intermediate‐grade intra‐prostatic prostate cancer using whole‐mount pathology: impact of the addition of 68 Ga‐ PSMA PET to mp MRI

inferred← citeshttps://doi.org/10.1111/bju.14999openalex-snapshot

Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross‐sectional study of the additive diagnostic value of gallium‐68 prostate‐specific membrane antigen positron‐emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for…

inferred← citeshttps://doi.org/10.1111/iju.13779openalex-snapshot

Positron‐emission tomography imaging in urological oncology: Current aspects and developments

inferred← citeshttps://doi.org/10.1136/bmjopen-2020-039735openalex-snapshot

Histopathological features of prostate cancer conspicuity on multiparametric MRI: protocol for a systematic review and meta-analysis

inferred← citeshttps://doi.org/10.1148/radiol.2018180788openalex-snapshot

Diagnostic Accuracy of 68Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer

inferred← citeshttps://doi.org/10.1155/2020/5363549openalex-snapshot

An Intelligent Decision-Making Support System for the Detection and Staging of Prostate Cancer in Developing Countries

inferred← citeshttps://doi.org/10.1158/0008-5472.can-20-1624openalex-snapshot

Cytoplasmic Localization of Prostate-Specific Membrane Antigen Inhibitors May Confer Advantages for Targeted Cancer Therapies

inferred← citeshttps://doi.org/10.1166/jbn.2018.2498openalex-snapshot

Intrinsically Zirconium-89-Labeled Manganese Oxide Nanoparticles for In Vivo Dual-Modality Positron Emission Tomography and Magnetic Resonance Imaging

inferred← citeshttps://doi.org/10.1177/17562872221105018openalex-snapshot

Role of molecular imaging in the detection of localized prostate cancer

inferred← citeshttps://doi.org/10.1186/s12880-025-01557-9openalex-snapshot

Which PSMA PET/CT interpretation criteria most effectively diagnose prostate cancer? a retrospective cohort study

inferred← citeshttps://doi.org/10.1186/s13014-018-1014-1openalex-snapshot

The dose distribution in dominant intraprostatic tumour lesions defined by multiparametric MRI and PSMA PET/CT correlates with the outcome in patients treated with primary radiation therapy for prostate cancer

inferred← citeshttps://doi.org/10.1186/s13014-018-1036-8openalex-snapshot

Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference

inferred← citeshttps://doi.org/10.1186/s13014-018-1047-5openalex-snapshot

PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives

inferred← citeshttps://doi.org/10.1186/s13014-020-01519-1openalex-snapshot

Recent advances of PET imaging in clinical radiation oncology

inferred← citeshttps://doi.org/10.1186/s13014-021-01758-wopenalex-snapshot

X-change symposium: status and future of modern radiation oncology—from technology to biology

inferred← citeshttps://doi.org/10.1186/s13244-020-00926-yopenalex-snapshot

Lesion-to-background ratio threshold value of SUVmax of simultaneous [68Ga]Ga-PSMA-11 PET/MRI imaging in patients with prostate cancer

inferred← citeshttps://doi.org/10.1186/s13550-021-00757-yopenalex-snapshot

Potential synergy between PSMA uptake and tumour blood flow for prediction of human prostate cancer aggressiveness

inferred← citeshttps://doi.org/10.1186/s13550-023-00984-5openalex-snapshot

Detecting localised prostate cancer using radiomic features in PSMA PET and multiparametric MRI for biologically targeted radiation therapy

inferred← citeshttps://doi.org/10.1186/s40644-022-00475-1openalex-snapshot

Gross tumor volume delineation in primary prostate cancer on 18F-PSMA-1007 PET/MRI and 68Ga-PSMA-11 PET/MRI

inferred← citeshttps://doi.org/10.1259/bjr.20180308openalex-snapshot

Theranostics of prostate cancer: from molecular imaging to precision molecular radiotherapy targeting the prostate specific membrane antigen

inferred← citeshttps://doi.org/10.1259/bjr.20201174openalex-snapshot

Prostate cancer GTV delineation with biparametric MRI and 68Ga-PSMA-PET: comparison of expert contours and semi-automated methods

inferred← citeshttps://doi.org/10.1259/bjr.20210670openalex-snapshot

Proton therapy for prostate cancer: current state and future perspectives

inferred← citeshttps://doi.org/10.1590/s1677-5538.ibju.2019.0817openalex-snapshot

68Ga-Prostate-specific membrane antigen (PSMA) positron emission tomography (pet) in prostate cancer: a systematic review and meta-analysis

inferred← citeshttps://doi.org/10.1590/s1677-5538.ibju.2020.0997openalex-snapshot

Prostate specific membrane antigen (PSMA) and Prostate Cancer Staging: is our current conventional staging obsolete?

inferred← citeshttps://doi.org/10.18383/j.tom.2019.00010openalex-snapshot

Automatic Tumor Segmentation With a Convolutional Neural Network in Multiparametric MRI: Influence of Distortion Correction

inferred← citeshttps://doi.org/10.21037/tlcr-20-805openalex-snapshot

Evolving target volume concepts in locally advanced non-small cell lung cancer

inferred← citeshttps://doi.org/10.2147/ijn.s137756openalex-snapshot

Surface-enhanced Raman spectroscopy of serum accurately detects prostate cancer in patients with prostate-specific antigen levels of 4–10 ng/mL

inferred← citeshttps://doi.org/10.2147/ijn.s561230openalex-snapshot

Cellular Synthesis of Targeted Ultrasound Molecular Imaging Probe and Its Application in Prostate Cancer Diagnosis

inferred← citeshttps://doi.org/10.21873/invivo.12187openalex-snapshot

Predicting Biochemical Failure in Irradiated Patients With Prostate Cancer by Tumour Volume Measured by Multiparametric MRI

inferred← citeshttps://doi.org/10.2217/fon-2017-0465openalex-snapshot

Biological Imaging for Individualized Therapy in Radiation Oncology: Part II Medical and Clinical Aspects

inferred← citeshttps://doi.org/10.2340/1651-226x.2025.44211openalex-snapshot

Ultra-hypofractionated radiotherapy with focal boost for high-risk localized prostate cancer (HYPO-RT-PC-boost): in silico evaluation with histological reference

inferred← citeshttps://doi.org/10.23736/s1824-4785.18.03059-5openalex-snapshot

Current application and future perspectives of prostate specific membrane antigen PET imaging in prostate cancer

inferred← citeshttps://doi.org/10.23736/s1824-4785.18.03080-7openalex-snapshot

PET imaging in adaptive radiotherapy of prostate tumors

inferred← citeshttps://doi.org/10.28982/josam.8201openalex-snapshot

Comparison of multiparametric prostate MR imaging and Ga-68 PSMA PET-CT imaging in prostate cancer staging

inferred← citeshttps://doi.org/10.2967/jnumed.116.186767openalex-snapshot

Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy

inferred← citeshttps://doi.org/10.2967/jnumed.117.191031openalex-snapshot

PSMA Ligands for PET Imaging of Prostate Cancer

inferred← citeshttps://doi.org/10.2967/jnumed.117.196444openalex-snapshot

The Utility of PET/CT in the Planning of External Radiation Therapy for Prostate Cancer

inferred← citeshttps://doi.org/10.2967/jnumed.118.221010openalex-snapshot

Combination of 68 Ga-PSMA PET/CT and Multiparametric MRI Improves the Detection of Clinically Significant Prostate Cancer: A Lesion-by-Lesion Analysis

inferred← citeshttps://doi.org/10.2967/jnumed.119.235333openalex-snapshot

68Ga-PSMA PET/CT Combined with PET/Ultrasound-Guided Prostate Biopsy Can Diagnose Clinically Significant Prostate Cancer in Men with Previous Negative Biopsy Results

inferred← citeshttps://doi.org/10.2967/jnumed.120.254623openalex-snapshot

Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network

inferred← citeshttps://doi.org/10.32592/ircmj.2021.23.8.1234openalex-snapshot

Image Fusion of X-ray and Magnetic Resonance Imaging-Based Evaluation of the Stability of Pediatric Lateral Humeral Condyle Fracture

inferred← citeshttps://doi.org/10.3389/fonc.2020.596756openalex-snapshot

Isotropic Expansion of the Intraprostatic Gross Tumor Volume of Primary Prostate Cancer Patients Defined in MRI—A Correlation Study With Whole Mount Histopathological Information as Reference

inferred← citeshttps://doi.org/10.3389/fonc.2020.600690openalex-snapshot

Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference

inferred← citeshttps://doi.org/10.3389/fonc.2021.652678openalex-snapshot

Influence of Urethra Sparing on Tumor Control Probability and Normal Tissue Complication Probability in Focal Dose Escalated Hypofractionated Radiotherapy: A Planning Study Based on Histopathology Reference

inferred← citeshttps://doi.org/10.3389/fonc.2022.880042openalex-snapshot

Intraindividual Comparison Between [18F] PSMA-1007 PET/CT and Multiparametric MRI for Radiotherapy Planning in Primary Prostate Cancer Patients

inferred← citeshttps://doi.org/10.3389/fonc.2023.1230251openalex-snapshot

Current status of PSMA-targeted imaging and therapy

inferred← citeshttps://doi.org/10.3390/bioengineering10080953openalex-snapshot

[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration

inferred← citeshttps://doi.org/10.3390/cancers12123523openalex-snapshot

Correlation between Intraprostatic PSMA Uptake and MRI PI-RADS of [68Ga]Ga-PSMA-11 PET/MRI in Patients with Prostate Cancer: Comparison of PI-RADS Version 2.0 and PI-RADS Version 2.1

inferred← citeshttps://doi.org/10.3390/cancers13225795openalex-snapshot

PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial

inferred← citeshttps://doi.org/10.3390/cancers14246194openalex-snapshot

Management of Patients with Recurrent and Metachronous Oligometastatic Prostate Cancer in the Era of PSMA PET

inferred← citeshttps://doi.org/10.3390/cancers15194888openalex-snapshot

Focal Boost in Prostate Cancer Radiotherapy: A Review of Planning Studies and Clinical Trials

inferred← citeshttps://doi.org/10.3390/cancers15245883openalex-snapshot

Evaluation of Recurrent Disease after Radiation Therapy for Patients Considering Local Salvage Therapy: Past vs. Contemporary Management

inferred← citeshttps://doi.org/10.3390/diagnostics8010016openalex-snapshot

Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer

inferred← citeshttps://doi.org/10.3390/diagnostics8040080openalex-snapshot

Imaging as a Personalized Biomarker for Prostate Cancer Risk Stratification

inferred← citeshttps://doi.org/10.3390/ph14080713openalex-snapshot

[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer

inferred← citeshttps://doi.org/10.3390/ph15101252openalex-snapshot

A Preclinical Study of an 125I-Labeled PSMA Ligand for Prostate-Cancer Puncture

inferred← citeshttps://doi.org/10.37004/sefm/2022.23.2.002openalex-snapshot

Modelo radiómico con PSMA-PET para la discriminación de pacientes con cáncer de próstata de alto riesgo

inferred← citeshttps://doi.org/10.4103/ijnm.ijnm_115_20openalex-snapshot

Discrepancy between Multiparametric Magnetic Resonance Imaging and 68Ga Prostate-Specific Membrane Antigen Positron Emission Tomography

inferred← citeshttps://doi.org/10.4103/wjnm.wjnm_59_18openalex-snapshot

Gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography compared with diagnostic computed tomography in relapsed prostate cancer

inferred← citeshttps://doi.org/10.4172/2155-9619.1000376openalex-snapshot

The Impact of a Bayesian Penalized-Likelihood Reconstruction Algorithm on a Dual-Time-Point Acquisition Protocol while Performing Ga-68-PSMA PET for Primary Prostate Cancer Detection

inferred← citeshttps://doi.org/10.4236/ami.2020.103003openalex-snapshot

Detection and Local Staging of Prostate Cancer by 68Ga-PSMA-PET/CT, Comparison with mpMRI and Histopathology

inferred← citeshttps://doi.org/10.5041/rmmj.10312openalex-snapshot

Multimodality Image Fusion with PSMA PET/CT and High-Intensity Focused Ultrasound Focal Therapy for Primary Diagnosis and Management of Prostate Cancer: A Planned Research Initiative

inferred← citeshttps://doi.org/10.5114/jcb.2017.69809openalex-snapshot

Focal therapy for prostate cancer: the technical challenges

inferred← citeshttps://doi.org/10.5334/jbsr.2832openalex-snapshot

A Comparative Study of Multiparametric MRI Sequences in Measuring Prostate Cancer Index Lesion Volume

inferred← citeshttps://doi.org/10.6084/m9.figshare.26585145openalex-snapshot

Additional file 1 of Detecting localised prostate cancer using radiomic features in PSMA PET and multiparametric MRI for biologically targeted radiation therapy

inferred← citeshttps://doi.org/10.7150/thno.23789openalex-snapshot

Surface impact on nanoparticle-based magnetic resonance imaging contrast agents

inferred← citeshttps://doi.org/10.7150/thno.32376openalex-snapshot

Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference

inferred← citeshttps://doi.org/10.7150/thno.47251openalex-snapshot

Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving 177 Lu-PSMA-617 Radioligand Therapy

inferred← citeshttps://doi.org/10.7150/thno.81938openalex-snapshot

Multiparametric magnetic resonance imaging for radiation therapy response monitoring in soft tissue sarcomas: a histology and MRI co-registration algorithm

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.